Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Flamel Technologies S.A. FLML

Healthcare Biotechnology
"Flamel Technologies SA is a specialty pharmaceutical company engaged in drug delivery and formulation development to create safer and more efficacious pharmaceutical products to address unmet medical needs and/or reduce overall healthcare costs."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FLML)

Flamel Technologies Doses First Patient in REST-ON Phase III Trial of FT218 for Excessive Daytime Sleepiness & Cataplexy

Marketwired December 16, 2016

Flamel Technologies to Present Jefferies 2016 London Healthcare Conference

Marketwired November 9, 2016

CORRECTION - Flamel Technologies Reports Third Quarter 2016 Results

Marketwired November 7, 2016

Flamel Technologies Reports Third Quarter 2016 Results

Marketwired November 7, 2016

Flamel Technologies to Report Third Quarter 2016 Results

Marketwired October 25, 2016

Mid-Morning Market Update: Markets Mostly Higher; Verizon Posts Mixed Q3 Results

Benzinga.com  October 20, 2016

Flamel Technologies Reaches Agreement With FDA on Protocol for Phase III Pivotal Trial of FT218

Marketwired October 6, 2016

Flamel Technologies to Present at Ladenburg Thalmann 2016 Healthcare Conference

Marketwired September 19, 2016

Flamel Technologies to Host Investor & Analyst Meeting

Marketwired September 19, 2016
View More News ››

Opinion & Analysis (NDAQ:FLML)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FLML)

RE: Amazed that

I am following it, i was a holder 6 months ago, I beleive that the price is very good considering the revenue this company generates...
brossob - March 15, 2005

Amazed that

nobody is following this one... eom
cassia - May 5, 2003
View more Bullboard ››

Pampa Metals Corp.

Pampa Metals Corp.

Pampa Metals is a CSE listed copper porphyry exploration company whose flagship project is the Piuquenes Copper-Gold-Silver ...
View More »